Institutional Knowledge Map (KMap)
Map
Services
How To Use
About
Toggle theme
Loading...
Menu
Pawel Laniewski
Researcher/Scientist IV
College of Medicine - Phoenix
Map Page
Research Area
microbiome,
microbiota,
bacterial vaginosis,
cervicovaginal microenvironment,
vaginal health,
vaccine development,
cancer,
epithelial cells,
campylobacter jejuni,
salmonella enterica
Grants
(5)
Identifying Immunometabolic Cervicovaginal Biomarkers for Early and Non-Invasive Diagnosis of Endometrial Cancer in Arizonans
Active
·
2023
·
$100K / $500K
·
External
Key Personnel (KP)
biomarkers,
endometrial cancer,
immunometabolic,
diagnosis,
cervicovaginal
Investigating Sneathia Species as Drivers of Gynecologic and Reproductive Disorders Using 3D Models of the Human Cervix
Active
·
2023
·
$120K / $150K
·
External
Principal Investigator (PI)
microbiome,
reproductive health,
infectious diseases,
gynecology,
3d modeling
Novel Gynecologic Cancer and Disease Diagnostic with at-home Test Collection
Active
·
2023
·
$0 / $100K
·
External
gynecologic cancer,
disease diagnostic,
at-home testing,
medical technology,
healthcare innovation
2/2 Partnership for Native American Cancer Prevention
2024
·
$2M / $1.3M
·
External
Key Personnel (KP)
cancer,
native american,
partnership,
prevention,
health disparities
Vaginal Bacteria as Oncogenic Drivers: Using a Human 3-D Endocervical Epithelial Cell Model to Investigate Bacterial Influence on Hallmarks of Cancer
2018
·
$2K / $20K
·
External
Co-Investigator (COI)
microbiome,
cancer,
cell model,
oncogenesis,
bacterial influence
Publications
(38)
Recent
Impact of chlorhexidine and povidone-iodine antiseptic solutions on the cervicovaginal microenvironment during laparoscopic hysterectomies: a pilot study
2024
antiseptic solutions,
cervicovaginal microenvironment,
laparoscopic hysterectomies,
impact
Supplementary Table 5 from Cervicovaginal Metabolome and Tumor Characteristics for Endometrial Cancer Detection and Risk Stratification
2024
Development of phenyllactic acid ionic liquids and evaluation of cytotoxicity to human cervical epithelial cells
2024
ionic liquids,
phenyllactic acid,
cytotoxicity,
cell evaluation,
development
Viewing Native American Cervical Cancer Disparities through the Lens of the Vaginal Microbiome: A Pilot Study
2024
cervical cancer,
native american health,
vaginal microbiome,
health disparities
A novel Gardnerella, Prevotella, and Lactobacillus standard that improves accuracy in quantifying bacterial burden in vaginal microbial communities.
2023
microbiome,
bacterial quantification,
vaginal health,
diagnostic tool,
bacterial communities
Preoperative quality of life at time of gynecologic surgery: considerations for postoperative management.
2023
quality of life,
gynecologic surgery,
preoperative assessment,
postoperative management,
patient outcomes
Commensal Lactobacilli Metabolically Contribute to Cervical Epithelial Homeostasis in a Species-Specific Manner
2023
cervical epithelial homeostasis,
lactobacilli metabolism,
commensal bacteria,
species-specific interaction,
microbiome influence
Cervicovaginal DNA Virome Alterations Are Associated with Genital Inflammation and Microbiota Composition
2022
viral genomics,
microbiota,
genital inflammation,
dna sequencing,
infectious diseases
Immunometabolic and potential tumor-promoting changes in 3D cervical cell models infected with bacterial vaginosis-associated bacteria
2022
immunometabolism,
tumor promotion,
infection,
cell models,
bacterial vaginosis
Connecting microbiome and menopause for healthy ageing
2022
microbiome,
menopause,
healthy ageing,
hormones,
immune system
Collaborations
(24)
Timian Godfrey
Mutual work: 1 Proposal﹒1 Grant
Collaboration Details
Cynthia Thomson
Mutual work: 1 Proposal﹒1 Grant
Collaboration Details
Melissa Herbst-Kralovetz
Mutual work: 16 Proposals﹒5 Techs﹒5 Grants﹒1 Supervisor
Collaboration Details
Denise Roe
Mutual work: 4 Proposals
Collaboration Details
Julie Armin
Mutual work: 1 Proposal﹒1 Grant
Collaboration Details
Page 1 of 5
Previous page
Next page
Techs/Patents
(5)
Methods for Guiding Treatments of Vulvovaginal Symptoms and Female Sexual Dysfunction
2023
·
Technology
Phenyllactic Acid: Antimicrobial Activity against Vaginal Microbiota and Cytotoxic Properties on Human Cervical Epithelial Cells
2023
·
Technology
Diagnostic for Non-Invasive Screening and Early Detection of Adenomyosis
2022
·
Technology
Diagnostic for Screening and/or Predicting Women "at risk" for the Development and Progression Endometrial Cancer
2021
·
Technology
Diagnostic for Monitoring Response to Immunotherapies for Gynecologic Cancer
2019
·
Technology
20+ Collaborators
$2.3M / $2.1M Funding
4+ Grants
30+ Publications
4+ Tech/Patents
